“Wonder Drugs” Continue On India Market Due To Lax Laws
This article was originally published in PharmAsia News
Executive Summary
Supplements and other products touted as wonder drugs to cure most major diseases continue to be sold in India because of lax laws controlling the industry. A physician complained the country has no laws allowing regulation of food and dietary supplements, so claims for therapies for complicated diseases go unchallenged. India has its Drugs and Magic Remedies Act, but it is rarely enforced even though drug regulators have the authority to act against misleading advertisements. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.